<?xml version="1.0" encoding="ISO-8859-1" ?><rss version="2.0"><channel><title>RTT - Long%20Term%20Stocks</title><link>http://www.rttnews.com</link><description>Global financial news, market analysis, economics and forex news</description><language>en-us</language><lastBuildDate>Sat, 07 Nov 2009 16:20:02 GMT</lastBuildDate><item><title>Ameren Q3 Profit Up; Tightens FY09 Core EPS View - Update </title><description>Public utility holding company Ameren Corp. (AEE) reported higher profit for the third quarter, as lower operating expenses offset the weak demand. The company also revised its earnings outlook for the full year.</description><link>http://www.rttnews.com/ArticleView.aspx?Id=1112282&amp;Category=Long%20Term%20Stocks</link><pubDate>Fri, 30 Oct 2009 14:50:49 GMT</pubDate></item><item><title>Vertex Pharma - Awaiting A New Beginning </title><description>At the 60th Annual Meeting of the American Association for the Study of Liver Diseases to be held between October 30 and November 3, 2009 in Boston, biotech firm Vertex Pharmaceuticals Inc. (VRTX) is scheduled to present data on its lead investigational HCV (hepatitis C virus) drug Telaprevir.</description><link>http://www.rttnews.com/ArticleView.aspx?Id=1089718&amp;Category=Long%20Term%20Stocks</link><pubDate>Fri, 09 Oct 2009 11:55:43 GMT</pubDate></item></channel></rss>
